Ondansetron-induced pseudoallergy with non-ischemic myocardial injury: A
rare case report of Kounis Syndrome
- Eden Firew,
- Helen Huang
, - Ayush Anand,
- Yonathan Asfaw,
- Charmy Parikh,
- Humza Khan
Eden Firew
American Medical Center
Corresponding Author:edenfirew24@gmail.com
Author ProfileHelen Huang
Royal College of Surgeons in Ireland Faculty of Medicine and Health Sciences
Author ProfileAbstract
Ondansetron is an FDA-approved selective serotonin 5-HT3 receptor
commonly indicated as an anti-emetic agent for nausea and vomiting. It
is rare to observe fatal reactions from ondansetron despite having no
allergies or previous exposure. We report a case of anaphylactoid
reaction with spontaneous coronary vasospasms in response to intravenous
ondansetron.18 Jul 2022Submitted to Clinical Case Reports 19 Jul 2022Submission Checks Completed
19 Jul 2022Assigned to Editor
23 Jul 2022Reviewer(s) Assigned
18 Sep 2022Review(s) Completed, Editorial Evaluation Pending
18 Sep 2022Editorial Decision: Revise Minor
19 Sep 20221st Revision Received
29 Nov 2022Submission Checks Completed
29 Nov 2022Assigned to Editor
29 Nov 2022Review(s) Completed, Editorial Evaluation Pending
08 Dec 2022Editorial Decision: Accept
